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Abstract
The biomechanical environment within the optic nerve head (ONH) is complex and is likely 
directly involved in the loss of retinal ganglion cells (RGCs) in glaucoma. Unfortunately, our 
understanding of this process is poor. Here we describe factors that influence ONH biomechanics, 
including ONH connective tissue microarchitecture and anatomy; intraocular pressure (IOP); and 
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cerebrospinal fluid pressure (CSFp). We note that connective tissue factors can vary significantly 
from one individual to the next, as well as regionally within an eye, and that the understanding of 
ONH biomechanics is hindered by anatomical differences between small-animal models of 
glaucoma (rats and mice) and humans. Other challenges of using animal models of glaucoma to 
study the role of biomechanics include the complexity of assessing the degree of glaucomatous 
progression; and inadequate tools for monitoring and consistently elevating IOP in animal models. 
We conclude with a consideration of important open research questions/challenges in this area, 
including: (i) Creating a systems biology description of the ONH; (ii) addressing the role of 
astrocyte connective tissue remodeling and reactivity in glaucoma; (iii) providing a better 
characterization of ONH astrocytes and non-astrocytic constituent cells; (iv) better understanding 
the role of ONH astrocyte phagocytosis, proliferation and death; (v) collecting gene expression 
and phenotype data on a larger, more coordinated scale; and (vi) developing an implantable IOP 
sensor.
1. Introduction
Previous controversies as to whether and how intraocular pressure (IOP) is important in the 
pathogenesis of glaucoma have faded over the past 20 years. There is now broad consensus 
among both scientists and clinicians that IOP and the mechanisms by which the relevant 
tissues respond to IOP are critical in the pathogenesis of glaucoma. It is also recognized that 
glaucomatous damage can be initiated at any level of IOP; further, additional genetic and/or 
environmental risk factors contribute to the eye-specific risk of developing the disease, some 
of which are IOP-related and some of which are IOP-independent. Nonetheless, while the 
biomechanical processes by which IOP contributes to retinal ganglion cell (RGC) axon 
damage within the optic nerve head (ONH) are considered to be a fundamental part of the 
pathogenesis of glaucoma, they are not fully understood.
This article focuses on the role of ONH biomechanics in glaucoma. For the purposes of this 
discussion we define the ONH to include the tissues within and immediately surrounding the 
scleral canal. In this article we identify fundamental questions and discuss the usefulness 
(including benefits and limitations) of various animal models to answer these questions. We 
will also identify important developments over the last five years and propose experiments 
for the next five years. Because the Lasker Meeting sessions dealing with astrocytes (Tamm 
et al., in preparation) and ONH biomechanics (the present report) were combined into a 
single discussion session, some overlap between the articles devoted to each session is 
necessary to ensure that each summary is complete.
2. Questions related to ONH structure and glaucoma susceptibility
We first focus on connective tissues elements of the ONH, principally the lamina cribrosa 
(LC) and peripapillary scleral (pp-sclera), since these elements provide the majority of the 
structural support to the ONH in the face of IOP. Are all humans formed equally with 
respect to the quality and quantity of their ONH connective tissues? The answer is almost 
certainly “no” for any genetically diverse species, including humans. Moreover, the 
Stowell et al. Page 2
Exp Eye Res. Author manuscript; available in PMC 2018 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
likelihood of intra-individual (between-eye) and regional (within-eye) differences in 
connective tissue properties and glaucomatous damage susceptibility must be borne in mind.
ONH connective tissue variability arises from both macro- and micro-architectural factors. 
Macro-architectural (anatomical) factors include the size and shape of the scleral canal; the 
thickness of the LC and pp-sclera; and LC beam and pore dimensions. Microarchitectural 
factors include the density, quantity, orientation and molecular nature of relevant fibrillar and 
non-fibrillar extracellular matrix (ECM) components, which ultimately depend on the ability 
of fibroblasts and astrocytes to robustly maintain and remodel ECM components. The micro-
architectural factors determine the local tissue material properties. We must also recall that 
each of these factors likely change with age and disease state. Taken together, differences in 
these factors will influence the biological, mechanical and physical properties of the ONH 
connective tissue elements.
The combination of macro-architecture (anatomic) features and material properties defines 
the overall structural stiffnesses of ONH connective tissues, which in turn dictate the 
magnitude of global and local deformations (strains) experienced by the ONH tissues for a 
given pressure-related load, including loads due to IOP, cerebrospinal fluid pressure (CSFp) 
and possibly even orbital pressure.
Apart from determining the material properties of a given connective tissue, 
microarchitectural features also influence diffusion coefficients (including those of signaling 
molecules) and the ease with which monocytes and macrophages pass into and within those 
tissues. These issues should be of special importance within the LC beams, as the lamina is 
the only location in the central nervous system where astrocyte processes do not directly 
contact local capillaries (Burgoyne, 2011; Hogan et al., 1971). Because the RGC axons have 
no direct blood supply within the LC, it is believed they are dependent upon local astrocytes 
for nutrient delivery. The ECM of LC beams, as well as the basal laminae of the LC beam 
endothelial cells and astrocytes, are thus potential barriers to nutrient delivery to the RGC 
axons within this region.
To further complicate the situation, signaling molecules that cause cells to modify ECM 
quality or quantity, such as those of the transforming growth factor-β (TGF-β) family, can 
bind to ECM components and be activated and released from the ECM in response to 
mechanical cues. Consequently those molecules likely play an important role in ONH 
biomechanics and its changes with aging and glaucoma (Burgoyne and Downs, 2008; Tamm 
et al., in preparation).
ONH connective tissues stiffen with age (Fazio et al., 2014a; Fazio et al., 2014b; Grytz et al., 
2014), although it is not clear if the individual components of those tissues stiffen at 
different rates. The process may not progress at comparable rates in all humans, as there is 
strong evidence that it is influenced by genetic factors (Fazio et al., 2014b). It is currently 
assumed that the LC contributes to RGC axon susceptibility within the ONH at all levels of 
IOP and at all ages, but the critical molecular components of this susceptibility remain 
unknown. Some humans develop glaucomatous optic neuropathy at low (“normal”) levels of 
IOP, while others can be followed with IOPs in the 30 – 40 mmHg range without evidence 
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of the neuropathy for 5 to 10 years (there currently are no studies that extend beyond 10 
years of follow up). Are there specific biological/mechanical/physical properties of the ONH 
connective tissues that can wholly or partially explain these differences in susceptibility?
With these concepts in mind, another question is: What are “good” and “bad” properties of 
the ONH connective tissues? One would presume that “good” properties are those that 
prevent reactive changes in ONH astrocytes and microglia, keep monocytes and 
macrophages out of the ONH, and facilitate normal function of RGC axons. Still, what is the 
exact role of those cells in glaucoma? Do glial cells become reactive to protect from 
neuronal damage or do they accelerate it? Is it better to have rigid or compliant ONH scleral 
connective tissue elements to achieve all or some of those goals? Alternatively, is a 
mismatch of a stiff LC and compliant sclera best? What makes for a robust versus a weak 
LC in terms of axonal preservation? These important questions remain unanswered.
A related point concerns the role of focal laminar defects (“pits”) (Irvine et al., 1986; Ohno-
Matsui et al., 2013). While it might be argued that a “good” LC is one without pits, pits 
might instead be beneficial strain relievers for the rest of the ONH connective tissue 
elements. Clinically, some patients have focal LC defects, and although RGC axons in the 
pit area will sustain damage regardless of the IOP, the rest of the ONH and its optic nerve 
axons remain stable. Overall, better phenotyping of the biomechanical responses of the ONH 
connective tissues along with improved molecular characterization is required to allow their 
contributions to RGC axon susceptibility to be determined.
Years ago, two laboratories independently demonstrated that in both monkeys (non-human 
primates) and humans the connective tissue beams of the LC are made of collagen I, III, and 
IV (the latter especially in the endothelial and astrocyte basal lamina), and elastin 
(Hernandez et al., 1990; Morrison et al., 1990; Morrison et al., 1988). The respective roles of 
those molecules for the biomechanical properties of the LC are as yet unclear. If monkeys 
could be genetically modified, the effects of changing collagen and elastin in the ONH 
scleral connective tissue elements (including the LC) could be assessed. Unfortunately, as of 
now, such genetic modifications are only feasible in mice in which the ONH contains a 
cellular (glial) rather than a connective tissue LC (Sun et al., 2009).
It should be noted that the biomechanical environment of the LC is intricately linked to that 
of the pp-sclera (Burgoyne et al., 2005; Sigal et al., 2009a, b), since the pp-sclera establishes 
the boundary conditions for the LC beam insertions into and through the scleral canal wall. 
The magnitude of pp-scleral load delivered to the LC is likely larger than the load due to the 
translaminar pressure difference (defined as IOP minus retrolaminar tissue pressure, which 
is close to or slightly above CSFp) at all levels of IOP. Currently, experiments designed to 
address the role of scleral stiffness in RGC axon insult in glaucoma are most common in 
rodent experimental glaucoma models. For example, experimental cross-linking of the 
scleral ECM increased stiffness and susceptibility to RGC damage in mice (Kimball et al., 
2014). Preliminary data published as abstract indicate a potentially different outcome in rats 
(Gonzalez P, et al. IOVS 2015; 56: ARVO E-Abstract 2006). Here, virally-mediated 
overexpression of bone morphogenetic protein 2 (BMP2), presumably acting by increasing 
the rigidity of the sclera, partially protected against IOP-induced optic nerve damage. Other 
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approaches may stiffen or loosen the sclera by alternative methods. Moreover, genetically 
modified mouse models are available which are deficient in specific ECM molecules or 
signaling pathways (including TGF-β). Taken together, rodent animal models are being used 
to address the biological and/or mechanical influences of the pp-sclera on glaucomatous 
ONH damage. However, because of their lack of a connective tissue LC (Tamm et al., in 
preparation) rodent models must be complemented with experiments in animals with a 
connective tissue LC.
3. Animal models of glaucoma
Since the Lasker meeting, a series of review articles on animal models in glaucoma have 
been published which are a recommended reference for the section that follows (Ethier et al., 
2015). Even though there is currently no animal model that mimics human glaucoma and its 
tremendous variability, models, when correctly implemented and interpreted, are valuable 
for addressing specific questions in glaucoma. There are, however, general limitations that 
need to be addressed
1. There is very little consensus on how to “stage” glaucoma in any species, other 
than to quantify retinal ganglion cell (RGC) somata or orbital optic nerve axons. 
The same endpoint defined in this way can be generated quickly at high IOP or 
slowly at low IOP. It is possible that different damage mechanisms are at work in 
each setting, some of which are not relevant for glaucoma in humans.
2. Even at a given level of RGC somata or optic nerve axon loss in an eye, there 
may be profound regional differences, i.e., some ONH regions within an optic 
nerve may appear normal, while other regions show early insult, and still other 
regions show profound alteration. Careful phenotyping is required to identify 
these differences, which may include molecular, cellular, and tissue-specific 
features. It is hoped that the effort to phenotype and stage the neuropathy (both 
its neural and connective tissue components) will ultimately lead to mechanistic 
insights, and vice versa.
3. There is great difficulty characterizing the magnitude of IOP insult in a given 
eye, regardless of species. For example, recent work indicates that IOP is highly 
dynamic, a feature not captured by standard “snapshot” IOP measurements 
(Downs, 2015). Continuous telemetric IOP monitoring may reveal which aspects 
of a given eye’s IOP profile are most important in models of glaucoma. 
Telemetric systems have been developed for monkeys and may be available for 
mouse and rat eyes in the near future.
4. To control IOP insult in animal models is difficult, which hampers the ability to 
perform studies designed to assess the effect of non-IOP-related risk factors, 
since such studies would ideally incorporate identical IOP insults in all treatment 
groups. Eventually the control of IOP insult should include programmable short- 
and long-term IOP fluctuation. This issue has led several groups to concentrate 
their efforts on manometer-controlled, short-term IOP elevations as a means of 
studying various factors contributing to ONH susceptibility (Crowston et al., 
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2015). There are also efforts to create longer-duration IOP-control systems in 
rodents (Bello et al., 2016).
The advantages and limitations of specific animal models are summarized below. For more 
detailed information the reader is referred to the articles of a special journal issue recently 
published on this topic, mentioned above (Ethier et al., 2015).
Monkey
Similar to the human, monkeys are mammals of the order Primates. Their ONH is 
anatomically and functionally very much like the human, including having a connective 
tissue LC, which is important when considering biomechanical factors in the ONH and 
comparing them with the situation in human. The size of monkey species used in biomedical 
research (frequently from the genus macaques) allows certain experiments to be done that 
are more difficult to perform in smaller animal models. Because of the fact that it is 
essentially (i.e. practically) impossible to obtain human tissues at the transition from ocular 
hypertension to the earliest stage of alterations/damage in glaucoma, the monkey model is, 
and will remain, very advantageous for longitudinally studying early ONH damage induced 
by high IOP.
Significant limitations include the cost, accessibility, and the difficulty of housing and 
working with monkeys. Monkeys share with humans the wide range of genetic variability 
that is especially problematic for studies involving genome-wide assessment profiles of 
proteomes or transcriptomes. Genetic engineering as performed in mice or rats is not 
feasible, though the use of viral vectors for gene transfer is increasing. While IOP telemetry 
has been achieved, the ability to control the magnitude and character of IOP insult, as noted 
above, has not.
Rats and mice
These rodent species have been widely used because they are available in inbred strains with 
genetically identical individuals, an advantage that theoretically minimizes the number of 
animals needed to obtain significant data after experiments. In addition, the fact that they 
can readily be genetically manipulated has revolutionized the field of biomedical research 
over the past decades. The Knockout Mouse Project (KOMP), a trans-NIH initiative, aims at 
generating a comprehensive and public resource comprised of mouse embryonic stem (ES) 
cells containing a null mutation in every gene in the mouse genome. Rats and mice are 
cheap, and easy to breed and house. Possibly the largest limitation to the use of rats and 
mice is their ONH anatomic differences compared to humans. Specifically, in the rat and 
mouse eye, the scleral canal is surrounded by pp-sclera, but contains no connective tissue 
beams forming a LC (Dai et al., 2012; Howell et al., 2007; Johansson, 1987; May and 
Lütjen-Drecoll, 2002; Sun et al., 2009). Just posterior to the pp-sclera, astrocytes form an 
enmeshing network termed the “glial lamina” through which the RGC axons pass (Dai et al., 
2012; Howell et al., 2007; Sun et al., 2009). Despite those differences in ONH structure, 
increased IOP induces ONH axonal degeneration in rats and mice indicating that the 
presence of a LC is not essential for the development of glaucomatous damage, at least in 
these species. In addition, there are differences to primates with regards to the ONH 
vasculature. In mouse ONH the central retinal vessels obliquely enter the optic nerve at the 
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level of the sclera (May and Lütjen-Drecoll, 2002). In contrast, in human and monkey they 
enter the optic nerve posterior to the LC (May, 2008). The rat ONH contains two scleral 
openings: a superior neurovascular opening and an inferior arterial opening, separated by a 
thin connective tissue (“scleral sling”) from the superior opening. The superior opening 
contains a vascular plexus that passes through the sclera and partially surrounds the optic 
nerve. The inferior scleral opening contains the central retinal artery and three long posterior 
ciliary arteries (Pazos et al., 2015a, b).
Rabbits
This species is more accessible and easier to breed and house than monkeys, and has 
considerable larger eyes than rats or mice, a fact that facilitates experimental procedures. 
Rabbits with hereditary congenital glaucoma and optic nerve damage in response to high 
IOP have been characterized (Bunt-Milam et al., 1987a, b). At the ONH, a poorly developed 
LC has been described with some connective tissue beams that radiate from the central 
retinal vessels to the optic nerve sheath (Flage, 1977). A significant difference to the human 
is the fact that rabbit RGC axon myelination begins on the retinal surface before the axons 
exit the eye (Vaney, 1980). In humans, myelination of optic nerve axons on the retina is 
rarely observed and appears to protect against IOP insult (Toh et al., 2011). A similar 
protective effect of myelination in the rabbit would be a confounding factor when using this 
species as animal model to assess ONH damage in glaucoma. Other limitations include the 
presence of a tremendous inflammatory response (Bito, 1984), and large anatomic 
differences in the vascular supply compared to primates. In the rabbit, retinal vessels are 
confined to a broad horizontal band coincident with the area covered by myelinated axons 
(De Schaepdrijver et al., 1989; Rohen, 1954).
New Animal Models
Pig, cat and dog eyes have a well-developed LC (Coudrillier et al., 2016a; Coudrillier et al., 
2016b; Fatehee et al., 2011; Grozdanic et al., 2010; Radius and Bade, 1982a, b), but their 
ONH vascular anatomy is considerably different to that of the human (De Schaepdrijver et 
al., 1989; May, 2008). Glaucoma commonly caused by anterior segment dysgenesis and high 
IOP is a frequent condition seen in cats and dogs (McLellan and Miller, 2011; Pizzirani, 
2015). Colonies of cats and dogs with hereditary glaucoma are available (Grozdanic et al., 
2010; Kuchtey et al., 2011; Narfstrom et al., 2013). The ONH of the guinea pig has laminar 
beams that are radially oriented, emanating from a central fibrovascular stalk (Morrison et 
al., 1995; Ostrin and Wildsoet, 2016). The guinea pig retina is avascular (De Schaepdrijver 
et al., 1989), which is a substantial difference to the human. Spontaneous glaucoma has not 
been reported for guinea pigs (Williams and Sullivan, 2010) and it is still uncertain whether 
or not animals of this species would develop glaucomatous damage after experimental 
elevation of IOP. A promising novel animal model for glaucoma research may be the tree 
shrew (family Tupaiidae), a non-rodent, primate-like species (Cao et al., 2003) that has been 
widely used in myopia research. The animals are easy to breed, inexpensive and their use in 
myopia research provides substantial knowledge of their scleral biology as well as the ability 
to study, in the same species, myopia, glaucoma and myopic eyes in which chronic IOP 
elevation has been introduced. A first characterization of the LC and scleral canal, and its 
ECM components in the normal tree shrew eye is available (Albon et al., 2007). In more 
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recent preliminary studies, magnetic beads were used for chamber angle occlusion in tree 
shrew eyes to achieve unilateral IOP elevations into the mid-20 mmHg range (Zhan W., et al. 
IOVS 2015; 56: ARVO E-Abstract 2428). After several weeks, thickness of the retinal nerve 
fiber layer was reduced in the treated eye. Moreover, in vivo SD-OCT imaging showed ONH 
and LD cupping in the glaucomatous eye of all animals, which was confirmed by 3-D 
histomorphometry. A high-quality genome sequence and the annotation of Chinese tree 
shrew are available (Fan et al., 2013). Still, questions remain how easily they can be 
genetically engineered.
In general, the differences between animal models, although a source of complexity, have 
the potential to inform us about the pathogenesis of glaucoma. There is no single model that 
best replicates human glaucoma and a diversity of models is needed to address the diversity 
of research questions in glaucoma.
4. Fundamental questions to be answered in animal models
Using the models discussed above, there are a number of questions that should be addressed 
to increase our understanding of glaucoma.
(1) Are ONH astrocytes fundamentally different from astrocytes in other regions of the 
central nervous system (CNS)? Glial lamina astrocytes of the mouse optic nerve appear to 
differ in structure from white matter astrocytes in other parts of the CNS, since the processes 
of individual astrocytes are far-reaching to span most of the width of the optic nerve (Sun et 
al., 2009), a structural peculiarity that could be explained by the unique spatial and 
biomechanical requirements of ONH astrocytes. It is unclear, but not necessarily unlikely, 
that ONH astrocytes also differ in their gene expression profile from other populations of 
astrocytes in the CNS. In order to address this important question and to analyze their gene 
expression profile, ONH and other astrocytes from different species, including humans, 
could be isolated, dissociated and sorted using cell-specific markers. This approach should 
be feasible for the mouse glial lamina, since mice are available with astrocytes that 
specifically express fluorescent markers such as GFP that could be used for cell sorting. A 
comparable approach could be used to isolate and molecularly characterize subpopulations 
of ONH astrocytes (if there are any). To achieve this goal, isolated cells could undergo 
transcription profiling using single-cell RNA sequencing (scRNA-seq).
Do ONH astrocytes of the normal and glaucomatous glial lamina (in species that lack a 
connective tissue LC) differ in their gene expression pattern from those that cover the LC 
beams in species that have a connective tissue LC? To date, while gene array studies have 
been performed in the ONH of animals with experimental glaucoma, the studies have only 
investigated the total RNA expression profile which included all cell types (Howell et al., 
2011; Johnson et al., 2011; Johnson et al., 2007).
(2) Why do some animal species have a connective tissue LC with beams containing 
capillaries covered by astrocytes while others have a glial lamina consisting of astrocytes 
and capillaries only, without additional connective tissue structural support? One hypothesis 
for the lack of a collagenous LC in the mouse is that in a relatively small, normal, healthy 
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eye at normal IOP, the additional structural support from collagenous beams may be 
unnecessary. Supporting evidence for this assumption comes from studies showing that 
single astrocytes are able to span the entire scleral canal in mice (Lye-Barthel et al., 2013; 
Sun et al., 2009). It would be important to know if this is also true in the rat, where the 
scleral canal is bigger. Some observations appear to support this concept but are not 
definitive on this point (Dai et al., 2012).
RGC axonal transport is obstructed within the ONH in response to high IOP, irrespective if 
there is a LC or a glial lamina. Thus, a LC obviously does not protect the RGC axons from 
transport difficulties. Could the evolutionary role of the LC be related to the size of the canal 
or the fact that the LC connective tissue beams are formed around the ONH capillaries? 
Connective tissue could prevent mechanical obstruction of capillaries. Alternatively, 
connective tissue might constitute a barrier against macrophage evasion from capillaries or 
change the activity of growth factors; for example, TGF-β being inactive when bound to 
ECM. The genes that control the development of a collagenous LC have not been identified 
and there are no human diseases that result in the complete absence of a LC. There are, 
however, congenital and acquired laminar pits (Irvine et al., 1986; Ohno-Matsui et al., 2013), 
which appear to be focal absences of the laminar insertion and can span several clinical 
clock hours.
(3) Are astrocytes and LC beam fibroblasts the only cells that synthetize the ECM of the LC 
beams? Astrocytes are characterized in part by their basal lamina and transmission electron 
microscopy studies have demonstrated the basal lamina to be integral with the LC beam 
ECM. During embryonic development of the human eye, the beams of the LC are formed in 
the second and third months of gestation by astrocytes that orient themselves 
perpendicularly to the ganglion cell axons (Morrison et al., 1989). The basal laminae of the 
astrocytes form the outer boundaries of the beams and label for laminin and collagen type 
IV. At the same time, neural crest-derived mesenchymal cells build the sclera while 
subsequent migration of these mesenchymal cells into the LC beams is presumably 
prevented by the astrocyte basal laminae. Still, around the nerve head (within the developing 
peripapillary sclera) there are mesenchymal cells that are very efficient in generating 
extracellular matrix, most likely more efficiently than the astrocytes (Morrison et al., 1989), 
Years ago it was proposed that in addition to astrocytes characterized by a basal lamina, 
there is another type of ONH cells, the so-called lamina cribrosa cells (lamina cribrocytes), 
which lack a typical basal lamina as seen by transmission electron microscopy of the LC 
(Hernandez, 2000) and in cultures from explants (Hernandez, Igoe and Neufeld, 1988). 
Lamina cribrocytes might indeed constitute a population of neural crest-derived 
mesenchymal cells that constitute the laminar beam fibroblasts in a mature eye. A 
comprehensive molecular characterization of LC cells should be performed in embryonic 
human eyes to differentiate localization and time of migration into the LC of neural crest-
derived cells (scleral fibroblasts and/or possible lamina cribrocytes) versus neural tube-
derived astrocytes.
(4) In the human eye, the LC ECM is rudimentary in premature eyes and its development is 
not completed until the late teenage years (Morrison et al., 1989). There is the distinct 
possibility that through human development the astrocytes experience physiologic levels of 
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biomechanical stress and strain and, in response, lay down collagen as a means of coping 
with it. It is of yet unclear if laminar beam capillaries differentiate first and then astrocytes 
migrate to them and lay down ECM including a basal lamina, or if the LC ECM forms at the 
same time as the capillaries. Careful studies to address those questions are warranted.
5. Recent developments
Over the last five years, an extensive body of research has been conducted in both animal 
models and humans leading to the following (selected) key developments:
1. In the area of biomechanics, important characterization of very early 
morphometric changes in the monkey ONH unilateral experimental glaucoma 
model has occurred (Yang et al., 2015). Briefly, the monkey ONH surface, LC, 
scleral canal and pp-sclera are compliant structures, demonstrating modest 
deformations that are reversible through an IOP range of 0 to 45mmHg. In a 
given eye, confocal laser scanning tomographic (CSLT)- and spectral domain 
OCT (SDOCT)-detected ONH surface compliance is not representative of 
underlying LC compliance. In subsets of eyes, scleral canal expansion and 
outward bowing of the pp-sclera are part of the ONH response to IOP. ONH 
finite element models in bilateral normal animals suggest that contralateral eyes 
exhibit similar mechanical behavior, and that local mechanical stress and strain 
correlate highly with local laminar connective tissue volume fraction (a measure 
of connective tissue density). Initial descriptions of decreased LC beam thickness 
and increased pore diameters within the superior and inferior scleral canal of 
monkey and human eyes were recently confirmed in 21 normal and control 
monkey eyes using three dimensional histomorphometric reconstruction (3D 
HMRN) techniques that regionalize the ONH tissues relative to the axis between 
the fovea and the center of Bruch’s membrane opening (the FoBMO axis).
2. In the area of glial cells, the discovery that resident astrocytes have a phagocytic 
role in the normal ONH is very important (Davis et al., 2014; Nguyen et al., 
2011). Changes in phagocytosis in reactive astrocytes might contribute to ONH 
axonal damage. Another important finding is the causative role of optic nerve 
monocytes/microglia for optic nerve degeneration in the mouse model of 
hereditary glaucoma (Howell et al., 2012).
6. Proposed experiments for the next five years
The following experiments are proposed to provide more knowledge on the role of 
biomechanics for astrocyte biology.
1. Create a systems biology description of the ONH including, but not limited to, 
RGC axons, constituent cells (astrocytes, endothelia, pericytes, fibroblasts, 
oligodendrocytes) connective tissue morphometry, biomechanics and blood flow.
2. Address the question of how astrocyte connective tissue remodeling and 
reactivity in response to IOP influences the ability to provide trophic support to 
the RGC axons within the ONH. The retina appears to be very different from the 
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ONH with regard to astrocyte reactivity. Extreme retinal astrocyte remodeling on 
the retinal surface occurs after retinal injury, but without any obvious signs of 
RGC death (Luna et al., 2016).
3. A complete molecular and morphometric characterization of the ONH astrocytes 
and non-astrocytic constituent cells is needed. This would include, but not be 
limited to, creating a catalog of molecular markers (through characterization of 
both RNA and protein changes) that astrocytes exhibit differentially in different 
contexts in response to tissue change. Moreover, it needs to be investigated 
whether susceptibility to astrocyte reactivity and RGC loss changes with age. 
Are there differences in absolute and relative aging? Some ECM proteins are 
made early and have hardly any turnover. Do these proteins contribute to an age-
dependent susceptibility to damage? Age-related differences in ONH 
susceptibility to elevated IOP are under study in mice, rat and monkey 
experimental glaucoma models.
4. The role of ONH astrocyte phagocytosis (Davis et al., 2014; Nguyen et al., 2011) 
needs to be explored in more detail. Astrocyte reactivity may reduce the cells’ 
ability to perform this essential function, leaving the RGC axons more 
susceptible to glaucomatous insult.
5. Proliferation and death of ONH astrocytes in the normal eye and in response to 
injury needs to be investigated. Is proliferation a consequence of IOP-induced 
mechanical strain and/or axonal degeneration? If astrocytes divide early in 
response to acute or chronic IOP elevation, would blocking of proliferation be 
beneficial or detrimental? If astrocytes die, can they regenerate? Do astrocytes 
migrate away from the LC beams (and their connections to capillary nutrient 
delivery) as part of “glaucomatous” reactivity?
6. Gene expression and phenotype data need to be collected on a larger, more 
coordinated scale. Databases of the genetic changes in all models need to be 
established.
7. There is need for better alignment of staging and outcome measures in all animal 
models of glaucoma.
8. The development of an implantable IOP sensor that is able to gather data at 
sufficiently high frequency, and is sensitive enough to determine IOP changes in 
individual patients/animals, is highly desirable. The data would allow a better 
understanding of how IOP affects disease progression. One of the issues with 
trying to classify the disease into various susceptibility phenotypes is that, 
because we don’t know much about one of the main drivers of the disease (IOP), 
we cannot effectively control for IOP. This in turn makes it difficult to isolate and 
understand other risk factors. Such an approach would ideally incorporate both 
IOP characterization and IOP control. Experiments could be designed to assess 
the effects of pressure (sustained, transient, spikes, prolonged, etc.) on retinal 
neurons and glial cells. In other experiments, the magnitude and character of IOP 
insult could be controlled and other risk factors could then be varied.
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